Oppenheimer Asset Management Inc. reduced its stake in Takeda Pharmaceutical Co. (NYSE:TAK – Free Report) by 6.1% in the 1st quarter, Holdings Channel reports. The institutional investor owned 55,466 shares of the company’s stock after selling 3,585 shares du…